InsidersTradesSigma
申报总数
公司
▲ 买入（18 笔）
▼ 卖出（17 笔）
内部人交易记录
其他已披露买入
18
已披露卖出
17
T+90 胜率
0%
T+90 平均收益
-7.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Viking Global Investors Lp. Officer active across 14 companies, notably Rallybio Corp. Aggregated, 51 disclosures have been recorded. Breakdown: 18 buys · 17 sells. Total volume traded: €1.1bn. Activity tracked since 2 September 2021. The latest transaction was filed on 7 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Viking Global Investors Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报51 总计
308,643 股@ US$32.25100.0% 占其流量Common StockSEC:0000905148-25-003555:0
3,500,000 股@ US$44.0046.8% 占其流量Common StockSEC:0000905148-25-002297:0
3,065,616 股@ US$34.9068.8% 占其流量Common StockSEC:0000905148-25-000306:0
39,032 股@ US$38.150.1% 占其流量Common StockSEC:0000905148-24-001732:1
39,032 股@ US$38.150.1% 占其流量Common StockSEC:0000905148-24-001733:1
1,912,750 股@ US$38.156.5% 占其流量Common StockSEC:0000905148-24-001732:0
1,912,750 股@ US$38.156.5% 占其流量Common StockSEC:0000905148-24-001733:0
6,305,866 股@ US$30.0081.4% 占其流量Common StockSEC:0000905148-24-001667:0
2,977,845 股@ US$34.259.0% 占其流量Common StockSEC:0000905148-24-000919:0
2,977,845 股@ US$34.259.0% 占其流量Common StockSEC:0000905148-24-000920:0
8,036,862 股@ US$24.6017.4% 占其流量Common StockSEC:0000905148-24-000844:0
8,036,862 股@ US$24.6017.4% 占其流量Common StockSEC:0000905148-24-000843:0
4,899,144 股Common StockSEC:0000905148-24-000814:0
4,899,144 股Common StockSEC:0000905148-24-000813:0
540,000 股@ US$19.5343.8% 占其流量Common StockSEC:0000905148-24-000092:0
6,300,817 股@ US$31.3017.0% 占其流量Common StockSEC:0000905148-24-000079:0
6,300,817 股@ US$31.3017.0% 占其流量Common StockSEC:0000905148-24-000080:0
864,509 股Common StockSEC:0000905148-23-000958:0
864,509 股Common StockSEC:0000905148-23-000959:0
511,627 股@ US$19.354.3% 占其流量Common StockSEC:0000905148-23-000804:0
标准退出：2023年11月26日 (T+90)
1,500,000 股@ US$35.0031.2% 占其流量Common StockSEC:0001140361-23-035288:0
110,756 股@ US$9.90100.0% 占其流量Common SharesSEC:0001140361-23-031459:0
850,000 股@ US$16.0056.2% 占其流量Common StockSEC:0001140361-23-024202:0
标准退出：2023年8月7日 (T+90)
2,459,880 股Class A Ordinary SharesSEC:0001140361-22-043107:0
567,532 股@ US$10.08100.0% 占其流量Common StockSEC:0001140361-22-040057:0
标准退出：2023年1月31日 (T+90)
51 条申报中的 25 条
About Viking Global Investors Lp
VIKING GLOBAL INVESTORS LP is a declarant with 51 filings in total. In the 51 recent filings sampled, the stated aggregate amounts are EUR 57,986,313 of buys and EUR 1,023,815,559 of sells, with filings ranging from 2016-02-08 to 2025-10-09. The companies listed are Editas Medicine, Inc., APi Group Corp, RayzeBio, Inc., BridgeBio Pharma, Inc., Inhibrx, Inc. and 4D Molecular Therapeutics, Inc., and the stated role for APi Group Corp is 10% Owner.
